онкология облучение после операции рак матки

Originally in researches GOG 111 and OV-10 it has been shown, that паклитаксел in a combination with цисплатином essentially improve results of treatment in comparison with a combination цисплатин-циклофосфан. High нейротоксичность combinations цисплатин-паклитаксел has made actual replacement цисплатина on карбоплатин. In several researches [Neijt J.P., AGO, GOG-158] it has been shown, that such replacement does not result in deterioration of the remote results and essentially improves bearableness of treatment. Then in research GOG-132 it is revealed, that at purpose{assignment} as combinations паклитаксела and цисплатина, and consecutive use of two preparations (цисплатина for the first line and паклитаксела for the second line), life expectancy of patients is identical. Thus, necessity of use таксанов at various stages of treatment for achievement of the best results has been once again underlined. Подробнее...

Hidalgo in 1998 publishes results of operations for 4 years with the average period of supervision 27 мес where does not mark any local relapse and also does not mark increase in number of complications after reconstruction [35]. Thus significant improvement of aesthetic results is emphasized. Thus the author suggests to carry out axillary лимфодиссекцию from separate access. Подробнее...